$ 321.17
Updated 01:00:00
Change % 0.00% Stock price unchanged
Change 0.00 Stock price unchanged
Volume 962,314
High $ 331.49
Low $ 320.39
Open $ 329.97
ISIN
Prev close $ 335.16
# of shares 196.71M
Market cap 63,177M USD
Intraday

Market closed
Biogen Inc
Market is closed, opens at 14:30
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  321.17 -3.5% Stock price decreasing -5.2% Stock price decreasing 1.8% Stock price increasing -6.9% Stock price decreasing 12.8% Stock price increasing
Powered by TradingView

News about Biogen Inc

  • English
  • Regulatory news
04 Jan
 
04 Jan
 
03 Jan
 
17 Dec
 
06 Dec
 
29 Nov
 
29 Oct
 
26 Oct
 
25 Oct
 
23 Oct
 

Related

Latest 1 week 1 month 3 months 6 months 1 year
YTD
 
Competitors Open
 
Abbott Laboratories 75.14 -0.1% Stock price decreasing 5.1% Stock price increasing 9.6% Stock price increasing 14.4% Stock price increasing 27.4% Stock price increasing 3.9% Stock price increasing
 
Bristol-Myers Squibb Company 50.13 -3.0% Stock price decreasing 0.8% Stock price increasing -5.8% Stock price decreasing -17.2% Stock price decreasing -24.0% Stock price decreasing -3.6% Stock price decreasing
 
Johnson & Johnson 135.42 -0.7% Stock price decreasing 5.1% Stock price increasing -4.6% Stock price decreasing 0.6% Stock price increasing 4.2% Stock price increasing 4.9% Stock price increasing
 
Pfizer Inc 42.14 -0.6% Stock price decreasing -0.3% Stock price decreasing -2.2% Stock price decreasing 0.2% Stock price increasing 17.9% Stock price increasing -3.5% Stock price decreasing
 
Amgen Inc 185.50 -1.5% Stock price decreasing -8.2% Stock price decreasing -3.8% Stock price decreasing -6.2% Stock price decreasing 1.7% Stock price increasing -4.7% Stock price decreasing
 
Novartis AG 90.51 0.7% Stock price increasing 2.5% Stock price increasing 1.7% Stock price increasing 8.1% Stock price increasing 6.2% Stock price increasing 5.5% Stock price increasing
 
GlaxoSmithKline PLC 40.54 -1.7% Stock price decreasing 4.0% Stock price increasing 0.1% Stock price increasing -2.4% Stock price decreasing 10.9% Stock price increasing 6.1% Stock price increasing
 
UCB 77.74 -1.3% Stock price decreasing 2.1% Stock price increasing 3.1% Stock price increasing -0.9% Stock price decreasing 13.5% Stock price increasing 9.0% Stock price increasing
 
Roche Hldg Sp.Adr 1/8 29.27 -1.6% Stock price decreasing 3.7% Stock price increasing 9.1% Stock price increasing 11.7% Stock price increasing 22.6% Stock price increasing 13.3% Stock price increasing
 
Sanofi SA ADR 1/2/EO 2 37.20 -0.5% Stock price decreasing 2.8% Stock price increasing -3.6% Stock price decreasing 0.5% Stock price increasing 15.5% Stock price increasing 1.6% Stock price increasing
 
Teva Pharmaceutical Industries.. 17.25 -4.1% Stock price decreasing -8.0% Stock price decreasing -21.7% Stock price decreasing -31.5% Stock price decreasing -12.9% Stock price decreasing 11.9% Stock price increasing

Company profile

Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva are marketed via a collaboration with Roche. Biogen also markets novel MS drugs Tysabri and Tecfidera. In Japan, Biogen's MS portfolio is co-promoted by Eisai. Hemophilia therapies Eloctate and Alprolix (partnered with SOBI) were spun off as part of Bioverativ in 2017. Biogen has several drug candidates in phase 3 trials in neurology and neurodegenerative diseases and has launched Spinraza with partner Ionis.

Peers

Instruments Last Change  
Abbott Labor.. 75.14 -0.5% Stock price decreasing
Bristol-Myer.. 50.13 -2.3% Stock price decreasing
Johnson & Jo.. 135.42 -0.7% Stock price decreasing
Pfizer Inc 42.14 -0.1% Stock price decreasing
Amgen Inc 185.50 0.0% Stock price unchanged
Novartis AG 90.51 -0.3% Stock price decreasing
GlaxoSmithKl.. 40.54 -2.0% Stock price decreasing
UCB 77.74 -0.5% Stock price decreasing
Roche Hldg S.. 29.27 0.9% Stock price increasing
Sanofi SA AD.. 37.20 -1.6% Stock price decreasing
Teva Pharmac.. 17.25 -0.9% Stock price decreasing

Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
22 February 2019 09:18:07
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: ReleaseBuild_20190215.1 - EUROWEB6 - 2019-02-22 10:18:07 - 2019-02-22 09:18:07 - 1000 - Website: OKAY